Long-term debt · 2016–2025

GSK long-term debt

$19.8B+8.0% · FY2025

GSK (GSK) reported $19.8B in long-term debt for fiscal 2025, +8.0% year on year.

$18.1B2016$19.3B2017$25.9B2018$31.1B2019$32.0B2020$27.7B2021$20.5B2022$19.3B2023$18.3B2024$19.8B2025
GSK — Long-term debt, 2016–2025
Fiscal yearLong-term debtChangeFiling
FY20252025-12-31$19.8B+8.0%Open →
FY20242024-12-31$18.3B−5.1%Open →
FY20232023-12-31$19.3B−5.6%Open →
FY20222022-12-31$20.5B−26.1%Open →
FY20212021-12-31$27.7B−13.3%Open →
FY20202020-12-31$32.0B+2.6%Open →
FY20192019-12-31$31.1B+20.0%Open →
FY20182018-12-31$25.9B+34.6%Open →
FY20172017-12-31$19.3B+6.8%Open →
FY20162016-12-31$18.1B—Open →

Long-term debt — Long-term debt is borrowing due more than a year out. A large figure is normal for capital-intensive businesses and says nothing on its own about financial health.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +1.0%

Figures are reported under IFRS in GBP and converted to US dollars at ECB reference rates — fiscal 2025 average 0.758 GBP/$ for income items, year-end 0.743 GBP/$ for balance-sheet items.

Long-term debt at companies of similar size

Full ranking by long-term debt →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=GSK long-term debt |url=https://companiesranked.com/en/company/gsk/long-term-debt |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). GSK long-term debt. CompaniesRanked. https://companiesranked.com/en/company/gsk/long-term-debt

BibTeX

@misc{companiesranked-en-company-gsk-long-term-debt-2026,
  author       = {{CompaniesRanked}},
  title        = {{GSK long-term debt}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/gsk/long-term-debt}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001131399-26-000004 · March 6, 2026

{{cite web |title=GSK long-term debt — 20-F (0001131399-26-000004) |url=https://www.sec.gov/Archives/edgar/data/1131399/000113139926000004/gsk-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-06}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← GSK overview